(EMAILWIRE.COM, November 27, 2018 ) Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies are driving the growth of the cell therapy segment.

Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=65442579

Browse and in-depth TOC on "Regenerative Medicine Market"
87 - Tables
38 - Figures
137 - Pages

The report segments this market based on types, therapy, application, and regions. Based on types, the Regenerative Medicine Market is segmented into cell-based products and acellular products. In 2016, cell-based products expected to dominate the global Regenerative Medicine Market. The key drivers includes the increasing awareness about stem cell therapy, growing funding for new stem cell lines, and development of advanced genomic methods for cell analysis.

View more detailed TOC @
https://www.marketsandmarkets.com/Market-Reports/regenerative-medicine-market-65442579.html

Based on therapy, the Regenerative Medicine Market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. The cell therapy segment is expected to account for the largest share of this market, increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies.

Request for Free Sample Report @
https://www.marketsandmarkets.com/requestsample.asp?id=65442579

Based on regions, the global Regenerative Medicine Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as technological advancement in the Regenerative medicine and rising incidences of chronic diseases and aging population.

Key players in the Regenerative Medicine Market include Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).